Moods Disorders Completed Phase 0 Trials for Midomafetamine (DB01454)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01951508Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI StudyBasic Science